Recurrence of primary Sclerosing Cholangitis after liver transplantation: Challenges, insights, and future directions
Digestive and Liver Disease · 2026
DOI: 10.1016/j.dld.2026.03.016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Digestive and Liver Disease, 2026. Verfasst von Hirushi Ravinga Weeraratne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery (Austin Health), The University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Liver Transplantation, Cholangitis, Sclerosing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Primary sclerosing cholangitis (PSC) is an immune-mediated fibro-obliterative disease of the biliary tree which culminates in biliary cirrhosis and decompensated liver failure. Increasing in incidence, PSC comprises a growing indication for liver transplantation (LT) with LT remaining the only proven life-prolonging therapy in patients with PSC. Recurrence of PSC (rPSC) after LT is however poorly understood and poses a further challenge due to heterogeneity in diagnostic criteria and proposed negative associations with graft failure and overall survival. This review explores the current literature surrounding rPSC including diagnosis, epidemiology, therapeutic options and patient outcomes. We discuss the challenges in the management of rPSC. Given the scarcity of literature and frequency of re-transplantation for rPSC, further clinical investigation is necessary to identify risk factors and effective therapies in this cohort of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery (Austin Health), The University of Melbourne, Melbourne, Victoria, Australia.
- Department of Medicine (Austin Health), The University of Melbourne, Melbourne, Victoria, Australia.
- Department of Surgery (Austin Health), The University of Melbourne, Melbourne, Victoria, Australia; Victorian Liver Transplant Unit, Austin Health, Melbourne, Victoria, Australia. Electronic address: marcos.perini@unime…
Zitieren
APA
Weeraratne, H. R., Alwis, S. M., Singh, M. P., Majumdar, A., & Perini, M. V. (2026). Recurrence of primary Sclerosing Cholangitis after liver transplantation: Challenges, insights, and future directions. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.03.016
Vancouver
Weeraratne HR, Alwis SM, Singh MP, Majumdar A, Perini MV. Recurrence of primary Sclerosing Cholangitis after liver transplantation: Challenges, insights, and future directions. Digestive and Liver Disease. 2026. doi:10.1016/j.dld.2026.03.016
BibTeX
@article{Weeraratne2026,
author = {Weeraratne, Hirushi Ravinga and Alwis, Samith Minu and Singh, Madhavi-Priya and Majumdar, Avik and Perini, Marcos Vinicius},
title = {Recurrence of primary Sclerosing Cholangitis after liver transplantation: Challenges, insights, and future directions},
journal = {Digestive and Liver Disease},
year = {2026},
doi = {10.1016/j.dld.2026.03.016}
}
EUVIMED